AP NEWS
Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Aphena Ready for Opioid Crisis Response Act

January 8, 2019

EASTON, Md.--(BUSINESS WIRE)--Jan 8, 2019--Aphena Pharma Solutions Inc. has announced the expansion of its blister packaging capacity with the purchase of a PharmaWorks TF2 blister packaging line with in-line cartoning capabilities, supplementing its recent vault enlargement to handle emerging requirements for DEA-controlled products. This expansion was driven by a recent increase in blister packaging demand, especially for DEA and FDA opioid-compliant packaging requests from clients.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190108005039/en/

The Pharmaworks TF2 blister packaging line (Photo: Business Wire)

“Aphena has a long history of CII packaging and an excellent compliance record with the FDA and DEA for over 15 years,” said Eric Allen, executive VP of sales and marketing at Aphena. “We have partnered with leading pharmaceutical companies to supply CII-V packaging, including both generic and brand medications.”

Anticipating significant growth in child-resistant compliance packaging for opioids and other products regulated by DEA and FDA, Aphena earlier this year added a new CII vault that more than quadrupled the current controlled pallet spaces. The company is also running nine packaging lines with serialization aggregation for blisters and bottles at its Cookeville, Tennessee, site.

“We can offer a large variety of blister tooling on site, which can handle both small and large doses of products for tablets, capsules and soft gels,” said Paul Glintenkamp, Aphena’s director of business development. “Additionally, our new blister line from PharmaWorks can accept existing tooling from our other blister packaging lines.”

Aphena has partnered with leading providers of compliance packaging technologies and can offer “off-the-shelf” or customized options for CII and child-resistant/senior-friendly package designs, including blisters, carding and reclosable systems. These also include clinically tested designs with the F=1 child-resistant/senior-friendly designation. As such, Aphena offers one of the industry’s broadest ranges of compliance packaging options.

Aphena Pharma Solutions Inc. is an industry-leading organization providing turnkey contract packaging and manufacturing solutions for the pharmaceutical, OTC, dietary supplement, animal health, consumer health and medical device markets. With two separate FDA- and DEA-registered, GDUFA-compliant and serialization-ready sites in the U.S., Aphena handles solid dose, liquids, gels, creams, ointments, foams, suspensions and lotions.

For more information about Aphena Pharma, visit aphenapharma.com or call 1-866-465-4506.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190108005039/en/

CONTACT: Aphena Pharma Solutions Inc.

Eric Allen, 1-866-465-4506

eallen@aphenapharma.com

KEYWORD: UNITED STATES NORTH AMERICA MARYLAND

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL MANUFACTURING PACKAGING

SOURCE: Aphena Pharma Solutions Inc.

Copyright Business Wire 2019.

PUB: 01/08/2019 10:00 AM/DISC: 01/08/2019 10:00 AM

http://www.businesswire.com/news/home/20190108005039/en

All contents © copyright 2019 The Associated Press.All rights reserved.